APA
Click to copy
Yamazaki, K., Mizukami, H., Yamada, T., Hara, Y., Tamba, H., Tatara, Y., … Hakamada, K. (2025). MEG3 Promoter Methylation and F11 Receptor (F11R) Overexpression Define a High-Risk Subtype of Diabetic Pancreatic Cancer. Modern Pathology, 39, 100953. https://doi.org/10.1016/j.modpat.2025.100953
Chicago/Turabian
Click to copy
Yamazaki, K., H. Mizukami, T. Yamada, Y. Hara, H. Tamba, Y. Tatara, Z. Wang, et al. “MEG3 Promoter Methylation and F11 Receptor (F11R) Overexpression Define a High-Risk Subtype of Diabetic Pancreatic Cancer.” Modern Pathology 39 (2025): 100953.
MLA
Click to copy
Yamazaki, K., et al. “MEG3 Promoter Methylation and F11 Receptor (F11R) Overexpression Define a High-Risk Subtype of Diabetic Pancreatic Cancer.” Modern Pathology, vol. 39, 2025, p. 100953, doi:10.1016/j.modpat.2025.100953.
BibTeX Click to copy
@article{yamazaki2025a,
title = {MEG3 Promoter Methylation and F11 Receptor (F11R) Overexpression Define a High-Risk Subtype of Diabetic Pancreatic Cancer},
year = {2025},
journal = {Modern Pathology},
pages = {100953},
volume = {39},
doi = {10.1016/j.modpat.2025.100953},
author = {Yamazaki, K. and Mizukami, H. and Yamada, T. and Hara, Y. and Tamba, H. and Tatara, Y. and Wang, Z. and Itaya, A. and Kushibiki, H. and Ryuzaki, M. and Sasaki, T. and Ruike, H. and Ogasawara, S. and Tu, Y. and Ishido, K. and Itoh, K. and Hakamada, K.}
}